What is the current stock price of Pardes Biosciences, Inc. (PRDS)?

As of the latest market data, Pardes Biosciences, Inc. (PRDS) is trading at $2.18. The stock has seen a gain of 0.93% today.

Does Pardes Biosciences, Inc. (PRDS) pay a dividend?

Based on current data, Pardes Biosciences, Inc. does not have a confirmed active dividend policy.

What is the market cap of Pardes Biosciences, Inc.?

The current market capitalization of Pardes Biosciences, Inc. (PRDS) is approximately unavailable.

PRDS

Pardes Biosciences, Inc.·Healthcare

2.18

0.926%(+0.02)

Market Closed

Last Updated: — ET

52W L: $0.7552W H: $3.67

Company Profile

Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. Its lead candidate is the PBI-0451 that is in clinical development stage to treat and prevent severe acute respiratory syndrome coronavirus 2 infections and associated diseases. The company was incorporated in 2020 and is headquartered in Carlsbad, California.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

2021-12-27

Beta

0.42

Websitewww.pardesbio.com↗